Stay updated on Guselkumab vs Ustekinumab in Psoriasis Clinical Trial

Sign up to get notified when there's something new on the Guselkumab vs Ustekinumab in Psoriasis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Guselkumab vs Ustekinumab in Psoriasis Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    Revision tag updated to v3.4.3, replacing the prior v3.4.2.
    Difference
    0.0%
    Check dated 2026-03-12T02:16:05.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    17 days ago
    No Change Detected
  4. Check
    31 days ago
    Change Detected
    Summary
    Revision: v3.4.2 is now displayed on the page, and the previous funding-status notice as well as Revision: v3.4.1 have been removed. No study content, eligibility criteria, or user actions are affected by this change.
    Difference
    0.3%
    Check dated 2026-02-11T14:08:23.000Z thumbnail image
  5. Check
    38 days ago
    Change Detected
    Summary
    Added a site-wide notice about a lapse in government funding, informing users that the NIH Clinical Center is open and linking to cc.nih.gov and opm.gov for status updates. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2026-02-04T10:20:42.000Z thumbnail image
  6. Check
    45 days ago
    Change Detected
    Summary
    Adds a glossary toggle (Show glossary) and exposes revised metadata fields (Last Update Submitted that Met QC Criteria, No FEAR Act Data) along with a new revision label (Revision: v3.4.0). The older QC criteria wording, the older FEAR Act wording (No FEAR Act data), and the previous revision tag (Revision: v3.3.4) are removed.
    Difference
    0.1%
    Check dated 2026-01-28T06:16:44.000Z thumbnail image
  7. Check
    59 days ago
    Change Detected
    Summary
    Revision updated from v3.3.3 to v3.3.4. No substantive content changes are visible in the screenshot; this appears to be a backend version update.
    Difference
    0.0%
    Check dated 2026-01-14T02:44:41.000Z thumbnail image
  8. Check
    81 days ago
    Change Detected
    Summary
    Added a comprehensive Locations section listing study sites across US states and Canadian provinces; removed prior location subsections and the HHS Vulnerability Disclosure as part of a revision.
    Difference
    2%
    Check dated 2025-12-23T17:16:47.000Z thumbnail image

Stay in the know with updates to Guselkumab vs Ustekinumab in Psoriasis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Guselkumab vs Ustekinumab in Psoriasis Clinical Trial page.